Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib, Tamoxifen, and Cisplatin in High-Risk Ocular Melanoma
NCT00489944Phase 2Unknown
- Sponsor
- San Diego Pacific Oncology & Hematology Associates
- Start
- May 2007
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in Ocular melanoma (OM), sponsored by San Diego Pacific Oncology & Hematology Associates. Status: unknown.
02
Drugs
sunitinib
03
Conditions
Ocular melanoma (OM)
Beyond the preview
Go deeper on NCT00489944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489944.